Many elderly people join 2nd stage of Nano Covax vaccine trials A total of 367 volunteers, including 30 aged over 60, have been injected with Nano Covax, Vietnam’s first homegrown COVID-19 vaccine candidate, in the second phase of its human trials, according to the Military Medical University.
The second stage has been conducted by the university and the Ho Chi Minh City-based Pasteur Institute since February 26. It has been carried out at the university in Hanoi and the medical centre of Ben Luc district in the southern province of Long An, with the participation of 560 volunteers aged from 12-75, including 80 aged over 60.
VIETNAM NEWS HEADLINES FEB. 28 Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công
28/02/2021 07:14 GMT+7
Vietnam has no COVID-19 case to report on February 28 morning
Vietnam saw no new COVID-19 case over the past 12 hours to 6am February 28, making the national tally unchanged at 2,432, according to the National Steering Committee for COVID-19 Prevention and Control.
Among the total, 1,530 were locally infected, including 837 cases since January 27.
A total 1,844 COVID-19 patients have recovered so far, and the death toll remains at 35.
Among those still under treatment, 32 have tested negative for SARS-CoV-2 once, 50 twice and 100 thrice.
By February 27 afternoon, 10 provinces and cities had gone through 14 consecutive days without new locally-infected cases of COVID-19.
Nearly 300 volunteers in Long An engage in second-stage trials of Nano Covax vir.com.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vir.com.vn Daily Mail and Mail on Sunday newspapers.
THREE first volunteers have received the first shots of a dose of 50mcg of Nanocovax Covid-19 vaccine.
Developed by the Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical University, Nanocovax is Vietnam’s first Covid-19 candidate vaccine to reach the human trial stage.
A total of 60 volunteers, aged 18 to 50, were selected for the first phase of clinical trials.
They were divided into three groups receiving three doses of 25mcg, 50mcg and 75mcg respectively. The vaccination consists of two injections 28 days apart.
After the injection, the volunteers were put under health monitoring at the Hanoi-based Military Medical University for 72 hours.
By VNA / DA NANG Today
December 27, 2020, 10:07 [GMT+7]
Three first volunteers received the first shot of a dose of 50mcg of Nanocovax Covid-19 vaccine on December 26 morning.
One of the three first volunteers receiving first shots of 50mcg dose of Covid-19 vaccine (Photo: VNA)
Developed by the Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical University, Nanocovax is Vietnam s first Covid-19 candidate vaccine to reach the human trial stage.
A total of 60 volunteers, aged 18-50, were selected for the first phase of the clinical trials. They are divided into three groups for receiving three doses of 25 mcg, 50 mcg and 75 mcg, respectively. The vaccination consists of two injections 28 days apart.